catechin has been researched along with Multiple Sclerosis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 5 (38.46) | 2.80 |
| Authors | Studies |
|---|---|
| Benlloch, M; Ceron, JJ; de la Rubia Ortí, JE; Platero, JL; Sabater, PS; Sancho, S; Sancho-Cantus, D; Tvarijonaviciute, A; Yang, IH | 1 |
| Araldi, GL; Hwang, YW | 1 |
| Benlloch, M; Carrera-Juliá, S; Ceron, JJ; Cuerda Ballester, M; de la Rubia Ortí, JE; Drehmer, E; López-Rodríguez, MM; Moreno, ML; Navarro, MÁ; Platero, JL; Tvarijonaviciute, A | 1 |
| Benlloch, M; de la Rubia Ortí, JE; Escribá-Alepuz, J; Franco-Martinez, L; Platero, JL; Sancho-Castillo, S; Tvarijonaviciute, A | 1 |
| Cai, F; Chen, G; Guo, X; Guo, Z; Jin, S; Lei, Y; Liu, S; Niu, X; Wang, Z; Xi, Y; Zhao, H; Zhu, D | 1 |
| Azarnia, M; Mashayekhi, F; Salehi, Z; Semnani, M | 1 |
| Benson, CA; Harris, C; Juzwik, CA; Monks, M; Plemel, JR; Ploughman, M | 1 |
| Bourdette, D; Devier, D; Foundas, A; Garrison, V; Koop, D; Kovner, B; Lovera, J; Ramos, A; Reza, T; Rooney, W | 1 |
| Bardua, M; Behrens, J; Bellmann-Strobl, J; Bock, M; Boschmann, M; Bremer, D; Füchtemeier, M; Gerhard, J; Hauser, AE; Herz, J; Infante-Duarte, C; Lindquist, R; Mähler, A; Millward, JM; Mossakowski, AA; Mothes, R; Niesner, R; Pache, FC; Paul, F; Pohlan, J; Pollok, K; Priller, J; Radbruch, H; Radbruch, M; Rinnenthal, JL; Viohl, L | 1 |
| Ganea, D; Hooper, KM; Kong, W | 1 |
| Meydani, SN; Ren, Z; Wang, J; Wu, D; Xiao, S; Xu, Y | 1 |
| Hu, X; Nie, H; Sun, Q; Wang, Y; Zhang, D; Zhang, S; Zhang, X; Zheng, Y | 1 |
| Aktas, O; Waiczies, S; Zipp, F | 1 |
2 review(s) available for catechin and Multiple Sclerosis
| Article | Year |
|---|---|
Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review.
Topics: Animals; Antioxidants; Catechin; Ginkgo biloba; Humans; Multiple Sclerosis; Nonprescription Drugs; Quercetin; Resveratrol; Stilbenes; Thioctic Acid | 2015 |
Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets.
Topics: Acyl Coenzyme A; Animals; Catechin; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Humans; Multiple Sclerosis; Nerve Degeneration; Neuroprotective Agents; T-Lymphocytes; TNF-Related Apoptosis-Inducing Ligand | 2007 |
4 trial(s) available for catechin and Multiple Sclerosis
| Article | Year |
|---|---|
Possible Role of Butyrylcholinesterase in Fat Loss and Decreases in Inflammatory Levels in Patients with Multiple Sclerosis after Treatment with Epigallocatechin Gallate and Coconut Oil: A Pilot Study.
Topics: Adipose Tissue; Adult; Antioxidants; Butyrylcholinesterase; Catechin; Coconut Oil; Dietary Supplements; Female; Humans; Inflammation; Lipid Metabolism; Male; Middle Aged; Multiple Sclerosis; Obesity; Pilot Projects; Weight Loss | 2021 |
Possible Reduction of Cardiac Risk after Supplementation with Epigallocatechin Gallate and Increase of Ketone Bodies in the Blood in Patients with Multiple Sclerosis. A Pilot Study.
Topics: 3-Hydroxybutyric Acid; Adult; Analysis of Variance; Anthropometry; Aryldialkylphosphatase; Body Mass Index; C-Reactive Protein; Cardiotonic Agents; Cardiovascular Diseases; Catechin; Dietary Supplements; Female; Heart Disease Risk Factors; Humans; Ketone Bodies; Male; Middle Aged; Multiple Sclerosis; Pilot Projects; Serum Albumin; Treatment Outcome; Waist-Height Ratio | 2020 |
Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies.
Topics: Adult; Catechin; Chemical and Drug Induced Liver Injury; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Neuroprotective Agents; Plant Extracts; Treatment Outcome | 2015 |
Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammation.
Topics: Animals; Antioxidants; Astrocytes; Calcium; Catechin; CD11b Antigen; Chronic Disease; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Glatiramer Acetate; Humans; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Fluorescence; Multiple Sclerosis; NADPH Oxidases; Neurons; Oxidative Stress | 2015 |
7 other study(ies) available for catechin and Multiple Sclerosis
| Article | Year |
|---|---|
Design, synthesis, and biological evaluation of polyphenol derivatives as DYRK1A inhibitors. The discovery of a potentially promising treatment for Multiple Sclerosis.
Topics: Catechin; Humans; Multiple Sclerosis; Phosphorylation; Polyphenols; Structure-Activity Relationship; Tea | 2022 |
Role of Haptoglobin as a Marker of Muscular Improvement in Patients with Multiple Sclerosis after Administration of Epigallocatechin Gallate and Increase of Beta-Hydroxybutyrate in the Blood: A Pilot Study.
Topics: 3-Hydroxybutyric Acid; Adult; Biomarkers; Catechin; Female; Haptoglobins; Humans; Interleukin-6; Male; Middle Aged; Multiple Sclerosis; Muscle, Skeletal; Pilot Projects | 2021 |
Epigallocatechin-3 gallate regulates macrophage subtypes and immunometabolism to ameliorate experimental autoimmune encephalomyelitis.
Topics: Animals; Catechin; Cell Differentiation; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Glycolysis; Humans; Macrophages; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Neuroprotective Agents; NF-kappa B; Signal Transduction; Tea; Th1 Cells; Th2 Cells | 2021 |
Effects of green tea epigallocatechin-3-gallate on the proteolipid protein and oligodendrocyte transcription factor 1 messenger RNA gene expression in a mouse model of multiple sclerosis.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Brain; Catechin; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Mice, Inbred C57BL; Multiple Sclerosis; Oligodendroglia; RNA, Messenger; Tea | 2017 |
The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in EAE through effects on Th1/Th17 differentiation and macrophage/microglia activation.
Topics: Animals; Arachidonate 5-Lipoxygenase; Catechin; Cell Differentiation; Cyclooxygenase Inhibitors; Cytokines; Drug Combinations; Encephalomyelitis, Autoimmune, Experimental; Female; Lipoxygenase Inhibitors; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Prostaglandin-Endoperoxide Synthases; Th1 Cells; Th17 Cells | 2016 |
Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets.
Topics: Animals; Catechin; CD4-Positive T-Lymphocytes; Cell Proliferation; Cytokines; Demyelinating Diseases; Dietary Supplements; Down-Regulation; Encephalomyelitis, Autoimmune, Experimental; Female; Mice; Mice, Inbred C57BL; Monocytes; Multiple Sclerosis; Myelin Proteins; Myelin-Oligodendrocyte Glycoprotein; Neuritis; Neuroprotective Agents; Nuclear Receptor Subfamily 1, Group F, Member 3; Random Allocation; T-Box Domain Proteins; T-Lymphocyte Subsets | 2012 |
Novel immunoregulatory properties of EGCG on reducing inflammation in EAE.
Topics: Animals; Antigen-Presenting Cells; Catechin; CD4-Positive T-Lymphocytes; Cell Differentiation; Encephalomyelitis, Autoimmune, Experimental; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis; STAT Transcription Factors; Th17 Cells | 2013 |